• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘治疗:茶碱

Asthma therapy: theophylline.

作者信息

Thomson N C

机构信息

University of Glasgow, Glasgow, United Kingdom.

出版信息

Can Respir J. 1998 Jul-Aug;5 Suppl A:60A-3A.

PMID:9753520
Abstract

Theophylline acts as a bronchodilator and has bronchoprotective activity in asthma. The importance of the anti-inflammatory properties of theophylline to its clinical efficacy remains uncertain. Theophylline has a place in management as an additional long term control medication for patients whose asthma is not controlled by an inhaled, short acting beta-agonists and inhaled steroid. For most patients an inhaled, long acting beta-agonist should be tried before oral theophylline. The relative efficacy and side effect profile of oral theophylline versus oral leukotriene modulators as an 'add on' therapy remain to be established.

摘要

茶碱作为一种支气管扩张剂,在哮喘中具有支气管保护活性。茶碱的抗炎特性对其临床疗效的重要性仍不确定。对于哮喘未被吸入短效β受体激动剂和吸入性类固醇控制的患者,茶碱作为一种额外的长期控制药物在治疗中占有一席之地。对于大多数患者,在使用口服茶碱之前应先尝试吸入长效β受体激动剂。口服茶碱与口服白三烯调节剂作为“附加”疗法的相对疗效和副作用情况仍有待确定。

相似文献

1
Asthma therapy: theophylline.哮喘治疗:茶碱
Can Respir J. 1998 Jul-Aug;5 Suppl A:60A-3A.
2
Low-dose theophylline: a new anti-inflammatory role in asthma management?
Monaldi Arch Chest Dis. 1996 Feb;51(1):30-4.
3
Theophylline.茶碱。
Am J Respir Crit Care Med. 2013 Oct 15;188(8):901-6. doi: 10.1164/rccm.201302-0388PP.
4
Pharmacological management of asthma.哮喘的药物治疗
Aust Fam Physician. 1998 Jan-Feb;27(1-2):64-8, 70.
5
Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.沙美特罗对接受吸入性糖皮质激素加茶碱治疗的持续性哮喘患者的影响。
Respiration. 2007;74(6):611-6. doi: 10.1159/000095678. Epub 2006 Sep 5.
6
Theophylline. A review of its potential steroid sparing effects in asthma.茶碱。关于其在哮喘中潜在的节省类固醇作用的综述。
Drugs. 1998 Dec;56(6):1081-91. doi: 10.2165/00003495-199856060-00018.
7
Theophylline revisited.再探茶碱
Allergy Asthma Proc. 2001 Nov-Dec;22(6):347-51.
8
A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.一项随机、开放标签、对照研究,旨在评估作为吸入性糖皮质激素和长效β2受体激动剂附加治疗药物的控制药物在治疗中重度持续性哮喘中的疗效和安全性。
J Postgrad Med. 2010 Oct-Dec;56(4):270-4. doi: 10.4103/0022-3859.70937.
9
Reassessment of the role of theophylline in the current therapy for nocturnal asthma.茶碱在当前夜间哮喘治疗中作用的重新评估。
J Am Board Fam Pract. 1992 May-Jun;5(3):281-8.
10
Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.茶碱对哮喘患者体内沙美特罗支气管保护作用耐受性的影响。
Am J Respir Crit Care Med. 1998 Sep;158(3):792-6. doi: 10.1164/ajrccm.158.3.9801036.

引用本文的文献

1
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.长效β2受体激动剂与茶碱用于哮喘维持治疗的比较
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001281. doi: 10.1002/14651858.CD001281.pub2.
2
Differential pharmacokinetics of theophylline in elderly patients.老年人中茶碱的药代动力学差异
Drugs Aging. 2003;20(1):71-84. doi: 10.2165/00002512-200320010-00005.